Aurinia Pharmaceuticals has started a Phase 3 clinical trial of voclosporin’s ability to treat lupus nephritis, a lupus-generated condition that causes kidneys to become inflamed and eventually fail. The double-blind, placebo-controlled AURORA trial (NCT03021499) will include about 320 patients. It will determine if a combination of voclosporin and a…
News
Researchers at Denver’s National Jewish Health have prevented autoimmune disease in mice prone to a lupus-like illness by eliminating a protein called T-bet. This protein, which helps transform a type of white blood cell into an age-associated B-cell (ABC), may be a possible therapeutic target for treating lupus, multiple sclerosis, Crohn’s disease…
The National Alliance for Hispanic Health is making a special effort during the current Lupus Awareness Month to increase awareness of the disease among Hispanics, including creating a Spanish-language fact sheet. “Very few Hispanics are aware of lupus, even though Hispanic women are among those with a higher prevalence of the disease,”…
Aurinia Pharmaceuticals has started a Phase 3 clinical trial of voclosporin, which eliminated an inflammatory kidney condition known as lupus nephritis in more than half of patients tested in a Phase 2b trial. The complete response rate of 49 percent of the patients in the Phase 2b trial was…
Poverty and race can cast shadows over lupus patients’ health outcomes, according to two studies. One study showed a connection between poverty and worse lupus-related health problems over time. The other showed that African-American and Hispanic women with lupus have higher rates of adverse pregnancy outcomes than whites. The poverty-related…
A partnership between two U.S. medical organizations, the Directors of Health Promotion & Education (DHPE) and the Chi Eta Phi Sorority of nurses and nursing students, is raising awareness of lupus among healthcare providers by holding education sessions at all five Chi Eta Phi regional conferences. The latest regional…
The reason why kidney disease strikes a lot of people with lupus has to do with the kind of disease lupus is, according to a Texas kidney expert who was interviewed about the connection between the conditions. Lupus is an autoimmune disease. The immune system produces antibodies to counter such a…
The French immunotherapy vaccine developer Neovacs joined with Lupus Europe to raise awareness of the disease on World Lupus Day yesterday. Neovacs develops vaccines for lupus and other autoimmune diseases. Lupus Europe is an umbrella organization of 24 patient associations in 22 countries. Paris-based Neovacs developed its proprietary Kinoid technology to target diseases associated…
Despite progress in diagnosing and managing lupus, 43 percent of those with the disease worry about the physical inactivity and social isolation it causes, finds a new survey released May 10 — World Lupus Day — by the World Lupus Federation (WLF). The Twitter poll, conducted among 2,048 people in…
The New York Legislature has passed a resolution recognizing Governor Andrew Cuomo’s proclamation of May as Lupus Awareness Month in the state. One of the resolution sponsors was the head of New York’s lower house, or Assembly, Fred W. Thiele Jr., whose daughter Josephine has lupus. The resolution builds on…
Recent Posts
- To my ‘forever nurse,’ who finally gave me my diagnosis of lupus
- New analyses show Benlysta may aid flare control, kidney health
- Can art therapy help lupus patients improve cognitive function?
- With chronic illness, checking in means asking, ‘How ya really doin’?’
- FDA approves Gazyva as lupus nephritis treatment